FDA Registered Establishment: What It Means and Doesn’t Mean

An FDA Registered Establishment is a facility that has completed FDA’s administrative device (or drug) establishment registration process under 21 CFR Part 807, Subpart B (for medical devices) — not a facility whose products FDA has approved, cleared, or certified. Registration tells FDA that a specific facility exists and what device-related activity happens there (manufacturing, repackaging, relabeling, sterilizing, or similar). It is a location-and-activity disclosure, not a product review.

For a buyer evaluating a medical-supply vendor’s compliance claims, this distinction matters because “FDA registered” is one of the most commonly overstated phrases in vendor marketing — often unintentionally, sometimes not. The fact itself is real and independently verifiable. The problem is what it gets stretched to imply.

What Establishment Registration Actually Confirms

Under 21 CFR Part 807, any US facility that manufactures, prepares, propagates, compounds, assembles, repackages, or relabels a medical device for commercial distribution — and most foreign facilities exporting devices into the US — must register annually with FDA and list the device categories associated with that activity (21 CFR Part 807, Subpart C covers listing separately from registration). Registration renews each year in a fixed window, October 1 through December 31, and each registered establishment is assigned an FEI (FDA Establishment Identifier) number, which also functions as its device registration number.

That is the entire substance of what registration confirms: this facility exists, it performs this device-related activity, and it told FDA so. FDA does not inspect the facility, review its quality system, or evaluate any specific product as a condition of registration itself — registration is processed administratively, not adjudicated.

What It Does Not Mean

FDA’s own regulation is explicit about the limits of registration. Under 21 CFR 807.39, “registration of a device establishment or assignment of a registration number does not in any way denote approval of the establishment or its products,” and “any representation that creates an impression of official approval because of registration or possession of a registration number is misleading and constitutes misbranding.” That is a direct legal constraint on how the fact can be marketed, not just a caveat.

In practice, registration is not:

• Not an approval or clearance. Whether a specific device may be legally marketed is a separate question, decided (where required) through 510(k) premarket notification or PMA approval — and even a 510(k) clearance itself, under 21 CFR 807.97, “does not in any way denote official approval of the device.”
• Not a quality certification. Registration says nothing about whether the facility’s quality management system conforms to any standard. That is a distinct, voluntary or separately-mandated process — see ISO 13485 certification and the device-quality requirements under 21 CFR Part 820 (QMSR), both of which involve actual audits FDA registration does not.
• Not an inspection result. A facility can be currently registered and still have open inspection findings. An FDA Form 483 or a Warning Letter is a separate enforcement record, not something registration status reflects either way.
• Not an endorsement of any kind. FDA does not vouch for, recommend, or stand behind a registered establishment’s business practices, pricing, or products.

The Registration / Listing / Clearance / Certification Stack

Buyers evaluating a vendor’s claims run into this alphabet of terms because each one answers a genuinely different question, and vendors don’t always distinguish them carefully:

• Establishment registration — does FDA know this facility exists and what it does? (21 CFR Part 807, Subpart B)
• Device listing — has the facility told FDA which device categories it markets from that location? (Subpart C — also administrative, also not a review)
• 510(k) clearance / PMA approval — has FDA made an actual determination about a specific device (substantial equivalence, or safety and effectiveness)? See FDA device classification, 510(k), and PMA pathways and 510(k) premarket notification for how that separate process actually works.
• Third-party quality certification (e.g. ISO 13485) — has an accredited external body audited the facility’s quality management system against a published standard? This is not an FDA process at all — FDA references ISO 13485:2016 in its Quality Management System Regulation, but the certification itself is issued by a certification body, not FDA.

A vendor can genuinely hold any one of these without holding the others. Registration is the loosest of the four, and the one buyers are most likely to see restated as if it covered ground it doesn’t.

Why an Unregistered Distributor Isn’t Automatically a Red Flag

The reverse mistake is just as common: assuming a distributor absent from FDA’s registration database must be operating irregularly. Registration under 21 CFR Part 807 applies to specific activities — manufacturing, repackaging, relabeling, and similar processing. Under 21 CFR 807.65, several categories are exempt outright, including retail and final-delivery establishments (“pharmacies, surgical supply outlets, or other similar retail establishments making final delivery or sale to the ultimate user”) and carriers transporting devices in the ordinary course of business. A wholesale distributor that only stores and ships devices without repackaging, relabeling, or otherwise processing them can legitimately fall outside the registration requirement entirely. Registration status, in either direction, is a narrow fact — confirm what activity a specific vendor actually performs before treating its presence or absence in the registry as evidence of anything broader.

How to Verify a Registration Claim

FDA publishes its device establishment registration and listing data as a public, searchable database (accessible via FDA’s own site). A registration or FEI number a vendor cites can be checked directly against that database to confirm the facility is currently registered and see what device activity is on file for it — which is the appropriate, proportionate use of the claim: confirming the narrow fact it actually represents, not treating it as a stand-in for product clearance or quality certification. For the fuller set of documents worth requesting before onboarding a new medical-supply vendor, see vendor onboarding: what documentation to request.

Related Terms

• FDA Form 483 — inspectional observations, a separate enforcement record from registration status.
• FDA 510(k) Premarket Notification
• FDA Medical Device Regulations: Classification, 510(k), and PMA Pathways
• ISO 13485 Certification
• 21 CFR Part 820 (QMSR)